Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention study

The use of Nasal Continuous Positive Airway Pressure Ventilation (NCPAP) has begun to increase and is progressively replacing conventional mechanical ventilation (MV), becoming the cornerstone treatment for newborn respiratory distress syndrome (RDS). However, NCPAP use in Lower-Middle Income Countr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC pediatrics 2015-03, Vol.15 (1), p.26-26, Article 26
Hauptverfasser: Rezzonico, Rossano, Caccamo, Letizia M, Manfredini, Valeria, Cartabia, Massimo, Sanchez, Nieves, Paredes, Zoraida, Froesch, Patrizia, Cavalli, Franco, Bonati, Maurizio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 26
container_issue 1
container_start_page 26
container_title BMC pediatrics
container_volume 15
creator Rezzonico, Rossano
Caccamo, Letizia M
Manfredini, Valeria
Cartabia, Massimo
Sanchez, Nieves
Paredes, Zoraida
Froesch, Patrizia
Cavalli, Franco
Bonati, Maurizio
description The use of Nasal Continuous Positive Airway Pressure Ventilation (NCPAP) has begun to increase and is progressively replacing conventional mechanical ventilation (MV), becoming the cornerstone treatment for newborn respiratory distress syndrome (RDS). However, NCPAP use in Lower-Middle Income Countries (LMICs) is poor. Moreover, bubble NCPAP (bNCPAP), for efficacy, cost effectiveness, and ease of use, should be the primary assistance technique employed in newborns with RDS. To measure the impact on in-hospital newborn mortality of using a bNCPAP device as the first intervention on newborns requiring ventilatory assistance. Prospective pre-intervention and post-intervention study. The largest Neonatal Intensive Care Unit (NICU) in Nicaragua. In all, 230 (2006) and 383 (2008) patients were included. In May 2006, a strategy was introduced to promote the systematic use of bNCPAP to avoid intubation and MV in newborns requiring ventilatory assistance. Data regarding gestation, delivery, postnatal course, mortality, length of hospitalisation, and duration of ventilatory assistance were collected for infants assisted between May and December 2006, before the project began, and between May and December 2008, two years afterwards. The pre- vs post-intervention proportion of newborns who died in-hospital was the primary end point. Secondary endpoints included rate of intubation and duration of NICU stay. Significant differences were found in the rate of intubation (72 vs 39%; p < 0.0001) and the proportion of patients treated exclusively with bNCPAP (27% vs 61%; p
doi_str_mv 10.1186/s12887-015-0338-3
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4376103</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541407994</galeid><sourcerecordid>A541407994</sourcerecordid><originalsourceid>FETCH-LOGICAL-b558t-646ec0c7b21136e607f52c2b7b5e50719e1e4cecb414b60897fce4f66f563fde3</originalsourceid><addsrcrecordid>eNp1ks9u1DAQxiMEou3CA3BBlpBQLyl24thZDpVWy7-VKuiBni3bmewaOXaInUX7ILwvDinVrlTkgy3Pb77xzOcse0XwFSE1exdIUdc8x6TKcVnWefkkOyeUk7ygJXl6dD7LLkL4gTHhNWXPs7OiquuKlvw8-73peqkj8i2KO0DhECJ0MhqNjIuDb0YdjXdT2PpfufYhIjUqZQE5GaRF69vVbUKRRF8367uJk6iBPVjfG7dF2o9J5vA-3faDDz0kuT2kM-RIugb1STBPlWDYg_tbKcSxObzInrXSBnh5vy-yu08fv6-_5DffPm_Wq5tcVVUdc0YZaKy5KggpGTDM26rQheKqggpzsgQCVINWlFDFcL3krQbaMtZWrGwbKBfZ9azbj6qDRqc3DNKKfjCdHA7CSyNOI87sxNbvRZodI2nmi-zDLKCM_4_AaUT7Tsy2iWSbmGwTk8zl_TsG_3OEEEVnggZrpQM_BkEYp2xJSjqhb2Z0Ky0I41qfdPWEi1WV-sR8uaSJunqESquBzmjvoDXp_iTh7VHCDqSNu-DtOHkSTkEygzr5GQZoH5olWEy_8tH2Xh-P-SHj3zcs_wDtf976</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1674691343</pqid></control><display><type>article</type><title>Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention study</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Rezzonico, Rossano ; Caccamo, Letizia M ; Manfredini, Valeria ; Cartabia, Massimo ; Sanchez, Nieves ; Paredes, Zoraida ; Froesch, Patrizia ; Cavalli, Franco ; Bonati, Maurizio</creator><creatorcontrib>Rezzonico, Rossano ; Caccamo, Letizia M ; Manfredini, Valeria ; Cartabia, Massimo ; Sanchez, Nieves ; Paredes, Zoraida ; Froesch, Patrizia ; Cavalli, Franco ; Bonati, Maurizio</creatorcontrib><description>The use of Nasal Continuous Positive Airway Pressure Ventilation (NCPAP) has begun to increase and is progressively replacing conventional mechanical ventilation (MV), becoming the cornerstone treatment for newborn respiratory distress syndrome (RDS). However, NCPAP use in Lower-Middle Income Countries (LMICs) is poor. Moreover, bubble NCPAP (bNCPAP), for efficacy, cost effectiveness, and ease of use, should be the primary assistance technique employed in newborns with RDS. To measure the impact on in-hospital newborn mortality of using a bNCPAP device as the first intervention on newborns requiring ventilatory assistance. Prospective pre-intervention and post-intervention study. The largest Neonatal Intensive Care Unit (NICU) in Nicaragua. In all, 230 (2006) and 383 (2008) patients were included. In May 2006, a strategy was introduced to promote the systematic use of bNCPAP to avoid intubation and MV in newborns requiring ventilatory assistance. Data regarding gestation, delivery, postnatal course, mortality, length of hospitalisation, and duration of ventilatory assistance were collected for infants assisted between May and December 2006, before the project began, and between May and December 2008, two years afterwards. The pre- vs post-intervention proportion of newborns who died in-hospital was the primary end point. Secondary endpoints included rate of intubation and duration of NICU stay. Significant differences were found in the rate of intubation (72 vs 39%; p &lt; 0.0001) and the proportion of patients treated exclusively with bNCPAP (27% vs 61%; p &lt;0.0001). Mortality rate was significantly reduced (40 vs 23%; p &lt; 0.0001); however, an increase in the mean duration of NICU stay was observed (14.6 days in 2006 and 17.5 days in 2008, p = 0.0481). The findings contribute to the evidence that NCPAP, particularly bNCPAP, is the first-line standard of care for efficacy, cost effectiveness, and ease of use in newborns with respiratory distress in LMICs. This is the first extensive survey performed in a large NICU from a LMICs, proving the efficacy of the systematic use of a bNCPAP device in reducing newborn mortality. These findings are an incentive for considering bNCPAP as an elective strategy to treat newborns with respiratory insufficiency in LMICs.</description><identifier>ISSN: 1471-2431</identifier><identifier>EISSN: 1471-2431</identifier><identifier>DOI: 10.1186/s12887-015-0338-3</identifier><identifier>PMID: 25885437</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Continuous Positive Airway Pressure - economics ; Continuous Positive Airway Pressure - methods ; Cost-Benefit Analysis ; Delivery, Obstetric ; Developing Countries ; Economic aspects ; Equipment and supplies ; Female ; Gestational Age ; Health aspects ; Hospital Mortality ; Humans ; Infant, Newborn ; Infants (Newborn) ; Intensive Care Units, Neonatal ; Length of Stay ; Male ; Methods ; Nicaragua ; Patient outcomes ; Prospective Studies ; Respiratory Distress Syndrome, Newborn - mortality ; Respiratory Distress Syndrome, Newborn - therapy</subject><ispartof>BMC pediatrics, 2015-03, Vol.15 (1), p.26-26, Article 26</ispartof><rights>COPYRIGHT 2015 BioMed Central Ltd.</rights><rights>Rezzonico et al.; licensee BioMed Central. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b558t-646ec0c7b21136e607f52c2b7b5e50719e1e4cecb414b60897fce4f66f563fde3</citedby><cites>FETCH-LOGICAL-b558t-646ec0c7b21136e607f52c2b7b5e50719e1e4cecb414b60897fce4f66f563fde3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376103/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376103/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25885437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rezzonico, Rossano</creatorcontrib><creatorcontrib>Caccamo, Letizia M</creatorcontrib><creatorcontrib>Manfredini, Valeria</creatorcontrib><creatorcontrib>Cartabia, Massimo</creatorcontrib><creatorcontrib>Sanchez, Nieves</creatorcontrib><creatorcontrib>Paredes, Zoraida</creatorcontrib><creatorcontrib>Froesch, Patrizia</creatorcontrib><creatorcontrib>Cavalli, Franco</creatorcontrib><creatorcontrib>Bonati, Maurizio</creatorcontrib><title>Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention study</title><title>BMC pediatrics</title><addtitle>BMC Pediatr</addtitle><description>The use of Nasal Continuous Positive Airway Pressure Ventilation (NCPAP) has begun to increase and is progressively replacing conventional mechanical ventilation (MV), becoming the cornerstone treatment for newborn respiratory distress syndrome (RDS). However, NCPAP use in Lower-Middle Income Countries (LMICs) is poor. Moreover, bubble NCPAP (bNCPAP), for efficacy, cost effectiveness, and ease of use, should be the primary assistance technique employed in newborns with RDS. To measure the impact on in-hospital newborn mortality of using a bNCPAP device as the first intervention on newborns requiring ventilatory assistance. Prospective pre-intervention and post-intervention study. The largest Neonatal Intensive Care Unit (NICU) in Nicaragua. In all, 230 (2006) and 383 (2008) patients were included. In May 2006, a strategy was introduced to promote the systematic use of bNCPAP to avoid intubation and MV in newborns requiring ventilatory assistance. Data regarding gestation, delivery, postnatal course, mortality, length of hospitalisation, and duration of ventilatory assistance were collected for infants assisted between May and December 2006, before the project began, and between May and December 2008, two years afterwards. The pre- vs post-intervention proportion of newborns who died in-hospital was the primary end point. Secondary endpoints included rate of intubation and duration of NICU stay. Significant differences were found in the rate of intubation (72 vs 39%; p &lt; 0.0001) and the proportion of patients treated exclusively with bNCPAP (27% vs 61%; p &lt;0.0001). Mortality rate was significantly reduced (40 vs 23%; p &lt; 0.0001); however, an increase in the mean duration of NICU stay was observed (14.6 days in 2006 and 17.5 days in 2008, p = 0.0481). The findings contribute to the evidence that NCPAP, particularly bNCPAP, is the first-line standard of care for efficacy, cost effectiveness, and ease of use in newborns with respiratory distress in LMICs. This is the first extensive survey performed in a large NICU from a LMICs, proving the efficacy of the systematic use of a bNCPAP device in reducing newborn mortality. These findings are an incentive for considering bNCPAP as an elective strategy to treat newborns with respiratory insufficiency in LMICs.</description><subject>Continuous Positive Airway Pressure - economics</subject><subject>Continuous Positive Airway Pressure - methods</subject><subject>Cost-Benefit Analysis</subject><subject>Delivery, Obstetric</subject><subject>Developing Countries</subject><subject>Economic aspects</subject><subject>Equipment and supplies</subject><subject>Female</subject><subject>Gestational Age</subject><subject>Health aspects</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infants (Newborn)</subject><subject>Intensive Care Units, Neonatal</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Methods</subject><subject>Nicaragua</subject><subject>Patient outcomes</subject><subject>Prospective Studies</subject><subject>Respiratory Distress Syndrome, Newborn - mortality</subject><subject>Respiratory Distress Syndrome, Newborn - therapy</subject><issn>1471-2431</issn><issn>1471-2431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1ks9u1DAQxiMEou3CA3BBlpBQLyl24thZDpVWy7-VKuiBni3bmewaOXaInUX7ILwvDinVrlTkgy3Pb77xzOcse0XwFSE1exdIUdc8x6TKcVnWefkkOyeUk7ygJXl6dD7LLkL4gTHhNWXPs7OiquuKlvw8-73peqkj8i2KO0DhECJ0MhqNjIuDb0YdjXdT2PpfufYhIjUqZQE5GaRF69vVbUKRRF8367uJk6iBPVjfG7dF2o9J5vA-3faDDz0kuT2kM-RIugb1STBPlWDYg_tbKcSxObzInrXSBnh5vy-yu08fv6-_5DffPm_Wq5tcVVUdc0YZaKy5KggpGTDM26rQheKqggpzsgQCVINWlFDFcL3krQbaMtZWrGwbKBfZ9azbj6qDRqc3DNKKfjCdHA7CSyNOI87sxNbvRZodI2nmi-zDLKCM_4_AaUT7Tsy2iWSbmGwTk8zl_TsG_3OEEEVnggZrpQM_BkEYp2xJSjqhb2Z0Ky0I41qfdPWEi1WV-sR8uaSJunqESquBzmjvoDXp_iTh7VHCDqSNu-DtOHkSTkEygzr5GQZoH5olWEy_8tH2Xh-P-SHj3zcs_wDtf976</recordid><startdate>20150325</startdate><enddate>20150325</enddate><creator>Rezzonico, Rossano</creator><creator>Caccamo, Letizia M</creator><creator>Manfredini, Valeria</creator><creator>Cartabia, Massimo</creator><creator>Sanchez, Nieves</creator><creator>Paredes, Zoraida</creator><creator>Froesch, Patrizia</creator><creator>Cavalli, Franco</creator><creator>Bonati, Maurizio</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150325</creationdate><title>Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention study</title><author>Rezzonico, Rossano ; Caccamo, Letizia M ; Manfredini, Valeria ; Cartabia, Massimo ; Sanchez, Nieves ; Paredes, Zoraida ; Froesch, Patrizia ; Cavalli, Franco ; Bonati, Maurizio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b558t-646ec0c7b21136e607f52c2b7b5e50719e1e4cecb414b60897fce4f66f563fde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Continuous Positive Airway Pressure - economics</topic><topic>Continuous Positive Airway Pressure - methods</topic><topic>Cost-Benefit Analysis</topic><topic>Delivery, Obstetric</topic><topic>Developing Countries</topic><topic>Economic aspects</topic><topic>Equipment and supplies</topic><topic>Female</topic><topic>Gestational Age</topic><topic>Health aspects</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infants (Newborn)</topic><topic>Intensive Care Units, Neonatal</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Methods</topic><topic>Nicaragua</topic><topic>Patient outcomes</topic><topic>Prospective Studies</topic><topic>Respiratory Distress Syndrome, Newborn - mortality</topic><topic>Respiratory Distress Syndrome, Newborn - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rezzonico, Rossano</creatorcontrib><creatorcontrib>Caccamo, Letizia M</creatorcontrib><creatorcontrib>Manfredini, Valeria</creatorcontrib><creatorcontrib>Cartabia, Massimo</creatorcontrib><creatorcontrib>Sanchez, Nieves</creatorcontrib><creatorcontrib>Paredes, Zoraida</creatorcontrib><creatorcontrib>Froesch, Patrizia</creatorcontrib><creatorcontrib>Cavalli, Franco</creatorcontrib><creatorcontrib>Bonati, Maurizio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rezzonico, Rossano</au><au>Caccamo, Letizia M</au><au>Manfredini, Valeria</au><au>Cartabia, Massimo</au><au>Sanchez, Nieves</au><au>Paredes, Zoraida</au><au>Froesch, Patrizia</au><au>Cavalli, Franco</au><au>Bonati, Maurizio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention study</atitle><jtitle>BMC pediatrics</jtitle><addtitle>BMC Pediatr</addtitle><date>2015-03-25</date><risdate>2015</risdate><volume>15</volume><issue>1</issue><spage>26</spage><epage>26</epage><pages>26-26</pages><artnum>26</artnum><issn>1471-2431</issn><eissn>1471-2431</eissn><abstract>The use of Nasal Continuous Positive Airway Pressure Ventilation (NCPAP) has begun to increase and is progressively replacing conventional mechanical ventilation (MV), becoming the cornerstone treatment for newborn respiratory distress syndrome (RDS). However, NCPAP use in Lower-Middle Income Countries (LMICs) is poor. Moreover, bubble NCPAP (bNCPAP), for efficacy, cost effectiveness, and ease of use, should be the primary assistance technique employed in newborns with RDS. To measure the impact on in-hospital newborn mortality of using a bNCPAP device as the first intervention on newborns requiring ventilatory assistance. Prospective pre-intervention and post-intervention study. The largest Neonatal Intensive Care Unit (NICU) in Nicaragua. In all, 230 (2006) and 383 (2008) patients were included. In May 2006, a strategy was introduced to promote the systematic use of bNCPAP to avoid intubation and MV in newborns requiring ventilatory assistance. Data regarding gestation, delivery, postnatal course, mortality, length of hospitalisation, and duration of ventilatory assistance were collected for infants assisted between May and December 2006, before the project began, and between May and December 2008, two years afterwards. The pre- vs post-intervention proportion of newborns who died in-hospital was the primary end point. Secondary endpoints included rate of intubation and duration of NICU stay. Significant differences were found in the rate of intubation (72 vs 39%; p &lt; 0.0001) and the proportion of patients treated exclusively with bNCPAP (27% vs 61%; p &lt;0.0001). Mortality rate was significantly reduced (40 vs 23%; p &lt; 0.0001); however, an increase in the mean duration of NICU stay was observed (14.6 days in 2006 and 17.5 days in 2008, p = 0.0481). The findings contribute to the evidence that NCPAP, particularly bNCPAP, is the first-line standard of care for efficacy, cost effectiveness, and ease of use in newborns with respiratory distress in LMICs. This is the first extensive survey performed in a large NICU from a LMICs, proving the efficacy of the systematic use of a bNCPAP device in reducing newborn mortality. These findings are an incentive for considering bNCPAP as an elective strategy to treat newborns with respiratory insufficiency in LMICs.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>25885437</pmid><doi>10.1186/s12887-015-0338-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2431
ispartof BMC pediatrics, 2015-03, Vol.15 (1), p.26-26, Article 26
issn 1471-2431
1471-2431
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4376103
source MEDLINE; Springer Nature - Complete Springer Journals; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Continuous Positive Airway Pressure - economics
Continuous Positive Airway Pressure - methods
Cost-Benefit Analysis
Delivery, Obstetric
Developing Countries
Economic aspects
Equipment and supplies
Female
Gestational Age
Health aspects
Hospital Mortality
Humans
Infant, Newborn
Infants (Newborn)
Intensive Care Units, Neonatal
Length of Stay
Male
Methods
Nicaragua
Patient outcomes
Prospective Studies
Respiratory Distress Syndrome, Newborn - mortality
Respiratory Distress Syndrome, Newborn - therapy
title Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A22%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20the%20systematic%20introduction%20of%20low-cost%20bubble%20nasal%20CPAP%20in%20a%20NICU%20of%20a%20developing%20country:%20a%20prospective%20pre-%20and%20post-intervention%20study&rft.jtitle=BMC%20pediatrics&rft.au=Rezzonico,%20Rossano&rft.date=2015-03-25&rft.volume=15&rft.issue=1&rft.spage=26&rft.epage=26&rft.pages=26-26&rft.artnum=26&rft.issn=1471-2431&rft.eissn=1471-2431&rft_id=info:doi/10.1186/s12887-015-0338-3&rft_dat=%3Cgale_pubme%3EA541407994%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1674691343&rft_id=info:pmid/25885437&rft_galeid=A541407994&rfr_iscdi=true